Health Care AI Offers Promise and Problems
Expanding use of generative artificial intelligence (AI) in health care has sparked talk of its possibilities while raising ethical questions. Healthcare Dive recently examined generative AI's potential, both positive and negative. From the article: "Generative AI is...
The REAL End of the COVID-19 National Health Emergency
You may have read that on April 10, President Biden signed House Joint Resolution 7, immediately terminating the national health emergency related to the COVID-19 pandemic under the National Emergencies Act. You also may recall that earlier this year, the Biden...
Biosimilars vs. Generics: What’s the Difference?
Much like generics are lower-cost equivalents of more expensive drugs, so too are biosimilars. But there's a notable distinction between the two. Generics contain the exact same active ingredients as their brand-name counterparts and are usually synthesized from...
Coming Soon… The 2023 Client Report!
In the upcoming 2023 MedBen Client Report, we'll be looking at some of the issues that affected our clients last year, and the ways we worked with them to find successful solutions to preserve or improve their benefits. "With health care inflation expected to double...
Get Actionable Insights with MedBen Analytics Reporting
MedBen Analytics offers a variety of customizable, downloadable reports to help you make informed decisions about changes to your plan. While there are dozens available to choose from, the most popular reports used by MedBen clients include: Utilization Metrics....
Why the Supreme Court’s Marietta Memorial v. DaVita Decision Matters
At this year's MedBen University roundtables, Senior Vice President & CPO Caroline Fraker provided an eye-opening example of why the June 2022 United States Supreme Court decision in the matter of Marietta Memorial Hospital Employee Health Benefit Plan v. DaVita...
Ohio Attorney General Sues PBMs, Calling Them ‘Modern Gangsters’
Ohio Attorney General David Yost has sued pharmacy benefit managers (PBMs) Express Scripts and Prime Therapeutics for conspiring to illegally increase prescription drug prices and force pharmacies to accept low reimbursement rates. Cigna Group and Humana were also...
MedBen Clients with Direct-to-Employer Contracting Keep Right to Audit Claims
Contracting directly with a health system offers employers pricing control, member access to high-quality local care, and the flexibility to create multiple benefit options. At this year's MedBen University roundtables, Regional Sales Director Brooke Hupp pointed out...
High Blood Pressure Linked to Dementia, Study Finds
A new study serves as a reminder that wellness promotes a healthy mind as well as a healthy body. According to an international team of researchers, there is a direct link between high blood pressure and dementia. Using information from genetic and imaging data and...
Drugmakers (Kind of) Lower Insulin Costs
Earlier this month, drug manufacturer Eli Lilly announced that it cutting the cost of two of its prescription brand insulins, Humalog and Humulin, by 70%, and capping out-of-pocket costs for privately insured patients at $35 a month. Competing drugmakers Novo Nordisk...
Overcoming Impact of Multi-Million-Dollar Claims Requires Proven Solutions
At the MedBen Broker Roundtable on March 16, Vice President of Sales & Marketing Brian Fargus discussed the trend of rising multi-million-dollar claims, and offered a variety of proven solutions. Citing a recent Sun Life high-cost claims analysis, Fargus said, "In...
Ensuring Health Privacy is a MedBen Priority
Following news that digital health companies GoodRx and BetterHelp shared sensitive user information with advertisers, the Federal Trade Commission (FTC) has requested funds for ensuring health privacy in its 2024 budget proposal. The budget request sites merger...